The relationship of HLA-G 14-bp insertion/deletion genetic polymorphism to the risk of multiple sclerosis and its clinical phenotypes

被引:1
作者
Farghaly, Wafaa M. [1 ]
Saad Eldien, Heba M. [2 ,3 ]
Sayed, Mohammed A.
Elnady, Hassan M. [4 ]
Khodeary, Ashraf [5 ]
Abdel-Gawad, Abdelhady R. [5 ]
El-Tallawy, Hamdy N. [1 ]
Abdellatif, Mohammed G. [4 ]
Alhewaig, Hazem K. [4 ]
机构
[1] Assiut Univ, Dept Neurol, Assiut, Egypt
[2] Jouf Univ, Dept Anat, Coll Med, Sakakah, Saudi Arabia
[3] Assiut Univ, Tissue Culture & Mol Biol Ctr, Histol & Cell Biol, Fac Med, Assiut, Egypt
[4] Sohag Univ, Dept Neurol, Fac Med, Sohag, Egypt
[5] Sohag Univ, Dept Clin Pathol, Fac Med, Sohag, Egypt
关键词
HLA-G; Multiple sclerosis; Polymorphism; 14-bp insertion; deletion; NATURAL-HISTORY; ASSOCIATION; EXPRESSION; PREVALENCE; FATIGUE; SERUM;
D O I
10.1186/s41983-021-00312-5
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background Human leukocyte antigen (HLA)-G molecule has been suggested to have a potential immunomodulatory role in multiple sclerosis (MS). Genetic variant sites of HLA-G molecule have been reported to be associated with autoimmune diseases. Identifying the genetic risk factors of MS may help in preventive strategies and anticipating disease progression. The aim of this work was to investigate the effect of HLA-G 14-base-pair insertion/deletion (14-bp INS/DEL) genetic polymorphism on MS risk and clinical characteristics and to observe the clinical characteristics of the MS patients' group. The study included 48 MS patients and 50 cross-matched healthy controls, who were recruited from Sohag and Assiut university hospitals. Genetic testing (14-bp Ins/Del gene polymorphism) using polymerase chain reaction (PCR) was performed for patients and control groups. All patients had a detailed clinical assessment and have undergone measurement of disability using the Expanded Disability Status Scale (EDSS). Results No statistically significant difference was found between MS patients and healthy controls (HC) in genotypic and allelic frequencies of HLA-G 14-bp INS/DEL polymorphism (P=0.305). No significant association was found between HLA-G 14-bp INS/DEL polymorphism genotypes and clinical characteristics or degree of disability of MS patients. The most frequent presenting symptoms of MS were motor symptoms. Fatigue was the most reported symptom along the course of MS disease. Conclusion Although it has been long known that HLA-G represents an important MS susceptibility locus, in this study, no significant relation could be detected between the 14-bp INS/DEL polymorphism genotype and MS susceptibility. MS risk susceptibility may be not linked to a single allele but may depend on the combination of different polymorphic genetic sites. In this study, the lack of genetic susceptibility may be attributed to ethnic factor.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] The relationship of HLA-G 14-bp insertion/deletion genetic polymorphism to the risk of multiple sclerosis and its clinical phenotypes
    Wafaa M. Farghaly
    Heba M. Saad Eldien
    Mohammed A. Sayed
    Hassan M. Elnady
    Ashraf Khodeary
    Abdelhady R. Abdel-Gawad
    Hamdy N. El-Tallawy
    Mohammed G. Abdellatif
    Hazem K. Alhewaig
    The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 57
  • [2] 14-bp Insertion/Deletion Polymorphism of the HLA-G Gene in Osteosarcoma Patients
    Moon, Ahrim
    Kim, Su Kang
    Chung, Joo-Ho
    Na, Ki Yong
    Olvi, Liliana G.
    Santini-Araujo, Eduardo
    Kim, Youn Wha
    Park, Yong-Koo
    KOREAN JOURNAL OF PATHOLOGY, 2011, 45 (05) : 485 - 490
  • [3] Relationship of HLA-G expression and its 14-bp insertion/deletion polymorphism with susceptibility to colorectal cancer
    Abu Hassan, M.
    Al Omar, S.
    Halawani, H.
    Arafah, M.
    Alqadheeb, S.
    Al-Tamimi, J.
    Mansour, L.
    GENETICS AND MOLECULAR RESEARCH, 2019, 18 (02):
  • [4] Association between sHLA-G and HLA-G 14-bp deletion/insertion polymorphism in Crohn's disease
    Zidi, Ines
    Ben Yahia, Hamza
    Bortolotti, Daria
    Mouelhi, Leila
    Laaribi, Ahmed Baligh
    Ayadi, Shema
    Zidi, Nour
    Houissa, Fatma
    Debbech, Radhouane
    Boudabous, Abdellatif
    Najjar, Taoufik
    Di Luca, Dario
    Rizzo, Roberta
    INTERNATIONAL IMMUNOLOGY, 2015, 27 (06) : 289 - 296
  • [5] The HLA-G 14-bp Insertion/Deletion Polymorphism in Recurrent Spontaneous Abortion among Iranian Women
    Afkhami, Fatemeh
    Khaniani, Mahmoud Shekari
    Farzadi, Layia
    Paknejad, Zeynab
    Derakhshan, Sima Mansoori
    IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY, 2014, 13 (05) : 364 - 369
  • [6] Association between HLA-G 14-bp insertion/deletion polymorphism and cancer risk: a meta-analysis
    Zhang, Shulong
    Wang, Hong Tao
    JOURNAL OF BUON, 2014, 19 (02): : 567 - 572
  • [7] HLA-G 14-bp Insertion/Deletion Polymorphism Is a Risk Factor for HTLV-1 Infection
    Haddad, Rodrigo
    Ciliao Alves, Daiani Cristina
    Rocha-Junior, Mauricio Cristiano
    Azevedo, Rochele
    Pombo-de-Oliveira, Maria do Socorro
    Takayanagui, Oswaldo Massaiti
    Donadi, Eduardo Antonio
    Covas, Dimas Tadeu
    Kashima, Simone
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2011, 27 (03) : 283 - 288
  • [8] An investigation into the association between HLA-G 14 bp insertion/deletion polymorphism and multiple sclerosis susceptibility
    Mohammadi, Nabiallah
    Adib, Minoo
    Alsahebfosoul, Fereshteh
    Kazemi, Mohammad
    Etemadifar, Masoud
    JOURNAL OF NEUROIMMUNOLOGY, 2016, 290 : 115 - 118
  • [9] Association of an HLA-G 14-bp Insertion/Deletion polymorphism with high HBV replication in chronic hepatitis
    Laaribi, A. B.
    Zidi, I.
    Hannachi, N.
    Ben Yahia, H.
    Chaouch, H.
    Bortolotti, D.
    Zidi, N.
    Letaief, A.
    Yacoub, S.
    Boudabous, A.
    Rizzo, R.
    Boukadida, J.
    JOURNAL OF VIRAL HEPATITIS, 2015, 22 (10) : 835 - 841
  • [10] Susceptibility role of soluble HLA-G and HLA-G 14-bp insertion/deletion polymorphism in inflammatory bowel disease
    Abdul-Hussein, Sarah S.
    Ali, Ekhlass N.
    Alkhalidi, Nawal M. F.
    Zaki, Neihaya H.
    Ad'hiah, Ali H.
    EGYPTIAN JOURNAL OF MEDICAL HUMAN GENETICS, 2020, 21 (01)